MétaCan
Menu
Back to cohort
Record W3114309787 · doi:10.30827/ars.v62i1.15684

Quercetin as a potential nutraceutic against coronavirus disease 2019 (COVID-19)

2021· article· es· W3114309787 on OpenAlexaff
Júlio César Moreira Brito, William Gustavo Lima, Waleska Stephanie da Cruz Nizer

Bibliographic record

VenueInstitutional Repository of the University of Granada (University of Granada) · 2021
Typearticle
Languagees
FieldComputer Science
TopicComputational Drug Discovery Methods
Canadian institutionsCarleton University
FundersFundação de Amparo à Pesquisa do Estado de Minas GeraisCoordenação de Aperfeiçoamento de Pessoal de Nível Superior
KeywordsCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakCoronavirusQuercetinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyDiseaseMedicineBiologyInfectious disease (medical specialty)Internal medicineOutbreakBiochemistry

Abstract

fetched live from OpenAlex

Introducción: La enfermedad del coronavirus 2019 (COVID-19) es una enfermedad viral que afecta a varios órganos y sistemas. Los tratamientos preventivos o profilácticos son especialmente útiles en enfermedades infecciosas
\nemergentes como COVID-19 porque reducen la necesidad de hospitalización y el gasto en salud pública. Aunque el
\nefecto preventivo del SARS-CoV-2 de varios agentes terapéuticos (e.g., hidroxicloroquina/cloroquina, remdesivir,
\nlopinavir y ritonavir) se ha evaluado ampliamente, ninguno de ellos ha demostrado una gran eficacia clínica.
\nMétodo: Por lo tanto, aquí nuestro objetivo es abordar y discutir los estudios publicados recientemente sobre el
\npotencial quimioprofilático de la quercetina contra el SARS-CoV-2. Metodología: Se realizó una búsqueda de la literatura en bases como PubMed/MEDLINE, Scielo, Scorpus, Web of Science, Cochrane Library y Clinical Trials.gov.
\nSe incluyeron y evaluaron críticamente estudios que abordan la quercetina contra el SARS-CoV-2 u otros tipos de
\ncoronavirus.
\nResultados: Algunos estudios han demostrado que la quercetina, un flavonoide aprobado por la FDA que se utiliza
\ncomo agente antioxidante y antiinflamatorio, inhibe la entrada del coronavirus (SARS-CoV) en la célula huésped.
\nAdemás, un estudio in silico mostró que la quercetina es un potente inhibidor de la proteasa principal del SARSCoV-2 (Mpro), lo que sugiere que este flavonoide también es activo contra COVID-19.
\nConclusiones: Debido a que la quercetina podría prevenir y disminuir la duración de las infecciones por SARSCoV-2, es plausible suponer que el uso profiláctico de este flavonoide produce varios beneficios clínicos. Pero, estas
\npruebas preliminares deben ser confirmadas mediante ensayos in vitro y, posteriormente, en un ensayo clínico
\naleatorizado.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies
Consensus categoriesScience and technology studies
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.482
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.001
Science and technology studies0.0060.007
Scholarly communication0.0000.001
Open science0.0020.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.260
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueInstitutional Repository of the University of Granada (University of Granada)Same topicComputational Drug Discovery MethodsFrench-language works237,207